Aillis

Aillis

An AI-powered medical device for early and accurate influenza detection.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor investor

€0.0

round
investor investor

€0.0

round
investor

€0.0

round
investor investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*

$3.3m

Valuation: $56.7m

Series D
Total Funding000k
Notes (0)
More about Aillis
Made with AI
Edit

Aillis is a Japanese company focused on developing artificial intelligence-powered medical devices. The firm's flagship product is "nodoca," a device designed for the diagnosis of influenza. This system utilizes a specialized camera to capture images of a patient's pharynx (throat) and combines this visual data with other information, such as body temperature, for analysis.

The core of nodoca is its AI algorithm, which examines the pharyngeal images to identify signs of influenza, aiming to replicate the diagnostic skills of experienced physicians. This approach offers a non-invasive method for influenza testing, providing a digital alternative to conventional diagnostic procedures.

The company operates in the MedTech and digital health sectors, targeting healthcare providers like hospitals and clinics as its primary clients. Its business model is centered on the development and provision of this specialized diagnostic tool to medical professionals, contributing to the field of AI-driven medical diagnostics.

Keywords: AI, medical device, influenza, diagnostics, MedTech, healthcare, image analysis, non-invasive, digital health, pharyngeal imaging

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo